Back
Gitlab, Inc. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
21
GTLB
Gitlab, Inc.
Last Price:
$38.19
Seasonality Move:
-20.64%
Sell
38
VKTX
Viking Therapeutics, Inc.
Last Price:
$34.23
Seasonality Move:
33.2%
Sell
21
Gitlab, Inc. (GTLB)
is a Sell
Is Gitlab, Inc. a Buy, Sell or Hold?
-
The current Gitlab, Inc. [GTLB] share price is $37.87. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $34.30. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTLB Stock Price Chart
What is Gitlab, Inc.'s stock price today?
-
The Gitlab, Inc. share price today is $37.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $34.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
GTLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.63 | Sell |
| Relative Strength Index (14 RSI): | 37.04 | Sell |
| Chaikin Money Flow: | -3379889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.53 - 43.39) | Sell |
| Bollinger Bands (100): | (41.46 - 48.44) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.74 | Buy |
| Relative Strength Index (14 RSI): | 41.99 | Sell |
| Chaikin Money Flow: | -1945381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.87 - 38.47) | Sell |
| Bollinger Bands (100): | (27.48 - 37.82) | Buy |
GTLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.17 | Sell |
| 20-day SMA: | 40.12 | Sell |
| 50-day SMA: | 43.97 | Sell |
| 200-day SMA: | 45.92 | Sell |
| 8-day EMA: | 38.92 | Sell |
| 20-day EMA: | 40.33 | Sell |
| 50-day EMA: | 42.79 | Sell |
| 200-day EMA: | 46.88 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.66 | Sell |
| 20-day SMA: | 36.1 | Sell |
| 50-day SMA: | 35.93 | Sell |
| 200-day SMA: | 30.12 | Buy |
| 8-day EMA: | 7.62 | Buy |
| 20-day EMA: | 3.27 | Buy |
| 50-day EMA: | 1.35 | Buy |
| 200-day EMA: | 0.34 | Buy |
Gitlab, Inc. Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Gitlab, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||